Scheduled Medicines Expert Committee

In 2016 the Ministerial Council endorsed the AHMAC Guidance for National Boards: Applications to the Ministerial Council for approval of endorsements in relation to scheduled medicines under section 14 of the National Law  (the AHMAC Guidance).

Consistent with the AHMAC Guidance, AHPRA has established a Scheduled Medicines Expert Committee (the Expert Committee) whose role is to advise National Boards on:

  • the use of scheduled medicines generally, and
  • matters relevant to a National Board’s proposal for a new scheduled medicines endorsement or an amendment to an existing scheduled medicines endorsement.

Information about committee members is available on the committee members page.

Terms of reference

Page reviewed 8/02/2018